In this episode, we’re diving into personalized medicine and drug delivery — and how cutting-edge tools like AI, automation,and robotics are transforming cancer care. Joining us in this episode is Jim Foote, Co-founder and CEO of First Ascent Biomedical. First Ascent is at the forefront of developing platforms that personalize therapy by leveraging advanced analytics and automation — with the goal of reducing trial-and-error in oncology and improving patient outcomes.
